Bionano Genomics, Inc. (BNGO)

SolarWinds Revenue

Bionano Genomics had revenue of $6.46M in the quarter ending March 31, 2025, a decrease of -26.37%. This brings the company's revenue in the last twelve months to $28.46M, down -24.04% year-over-year. In the year 2024, Bionano Genomics had annual revenue of $30.78M, down -14.79%.

• Revenue (ttm): $28.46M
• Revenue Growth: -24.04%
• P/S Ratio: 0.18
• Revenue / Employee: $284,640
• Employees: 100
• Market Cap: 9.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	30.78M	-5.34M	-14.79%
Dec 31, 2023	36.12M	8.31M	29.90%
Dec 31, 2022	27.80M	9.82M	54.62%
Dec 31, 2021	17.98M	9.48M	111.47%
Dec 31, 2020	8.50M	-1.63M	-16.06%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.